Marios Dimitriou

1.4k total citations
17 papers, 465 citations indexed

About

Marios Dimitriou is a scholar working on Hematology, Molecular Biology and Genetics. According to data from OpenAlex, Marios Dimitriou has authored 17 papers receiving a total of 465 indexed citations (citations by other indexed papers that have themselves been cited), including 10 papers in Hematology, 8 papers in Molecular Biology and 5 papers in Genetics. Recurrent topics in Marios Dimitriou's work include Acute Myeloid Leukemia Research (10 papers), RNA modifications and cancer (4 papers) and Histone Deacetylase Inhibitors Research (3 papers). Marios Dimitriou is often cited by papers focused on Acute Myeloid Leukemia Research (10 papers), RNA modifications and cancer (4 papers) and Histone Deacetylase Inhibitors Research (3 papers). Marios Dimitriou collaborates with scholars based in Sweden, United Kingdom and United States. Marios Dimitriou's co-authors include Dimitris L. Kontoyiannis, Eva Hellström‐Lindberg, Christina Eftychi, Ioannis Karakasiliοtis, Anthie Yiakouvaki, Stamatis Theocharis, Monika Jansson, Teresa Mortera‐Blanco, Mohsen Karimi and Petter Woll and has published in prestigious journals such as Journal of Clinical Investigation, Nature Communications and Blood.

In The Last Decade

Marios Dimitriou

17 papers receiving 461 citations

Peers — A (Enhanced Table)

Peers by citation overlap · career bar shows stage (early→late) cites · hero ref

Name	h						Papers	Cites
Marios Dimitriou Sweden	13	308	165	98	76	70	17	465
Nahoko Nishimoto Japan	10	216 0.7×	296 1.8×	60 0.6×	54 0.7×	76 1.1×	13	476
Alice Marceau‐Renaut France	11	200 0.6×	400 2.4×	90 0.9×	58 0.8×	143 2.0×	42	505
Yu‐Jun Dai China	11	308 1.0×	174 1.1×	95 1.0×	87 1.1×	47 0.7×	25	488
Carl Sandén Sweden	11	198 0.6×	187 1.1×	54 0.6×	137 1.8×	53 0.8×	18	426
Katherine E. Lindblad United States	10	217 0.7×	127 0.8×	70 0.7×	122 1.6×	56 0.8×	14	393
Rika Kanezaki Japan	11	198 0.6×	163 1.0×	40 0.4×	68 0.9×	78 1.1×	19	387
Matthew Ndonwi United States	9	318 1.0×	242 1.5×	57 0.6×	47 0.6×	109 1.6×	11	486
Angela Minervini Italy	14	221 0.7×	214 1.3×	139 1.4×	31 0.4×	128 1.8×	38	483
Cara Lunn Shirai United States	8	331 1.1×	205 1.2×	69 0.7×	44 0.6×	76 1.1×	16	439
Hiroyoshi Kunimoto Japan	9	183 0.6×	205 1.2×	50 0.5×	55 0.7×	93 1.3×	23	425

Countries citing papers authored by Marios Dimitriou

Since Specialization

Citations

This map shows the geographic impact of Marios Dimitriou's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Marios Dimitriou with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Marios Dimitriou more than expected).

Fields of papers citing papers by Marios Dimitriou

Since Specialization

Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Marios Dimitriou. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Marios Dimitriou. The network helps show where Marios Dimitriou may publish in the future.

Co-authorship network of co-authors of Marios Dimitriou

This figure shows the co-authorship network connecting the top 25 collaborators of Marios Dimitriou. A scholar is included among the top collaborators of Marios Dimitriou based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Marios Dimitriou. Marios Dimitriou is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

Sort: Min cites: Since: Top N: Style:

17 of 17 papers shown

Mälarstig, Anders, Felix Graßmann, Marios Dimitriou, et al.. (2023). Evaluation of circulating plasma proteins in breast cancer using Mendelian randomisation. Nature Communications. 14(1). 7680–7680. 19 indexed citations

Dimitriou, Marios, Teresa Mortera‐Blanco, Magnus Tobiasson, et al.. (2023). Identification and surveillance of rare relapse-initiating stem cells during complete remission after transplantation. Blood. 143(11). 953–966. 5 indexed citations

Cieśla, Maciej, Phuong Cao Thi Ngoc, Sowndarya Muthukumar, et al.. (2023). m6A-driven SF3B1 translation control steers splicing to direct genome integrity and leukemogenesis. Molecular Cell. 83(7). 1165–1179.e11. 21 indexed citations

Guzzi, Nicola, Sowndarya Muthukumar, Maciej Cieśla, et al.. (2022). Pseudouridine-modified tRNA fragments repress aberrant protein synthesis and predict leukaemic progression in myelodysplastic syndrome. Nature Cell Biology. 24(3). 299–306. 78 indexed citations

Mortera‐Blanco, Teresa, Pedro Luís Moura, Gunilla Walldin, et al.. (2022). The extent of residual WT HSPCs is associated with the degree of anemia in patients with SF3B1-mutated MDS-RS. Blood Advances. 6(16). 4705–4709. 2 indexed citations

Lindqvist, Birgitta, Sara Svensson Akusjärvi, Anders Sönnerborg, Marios Dimitriou, & J. Peter Svensson. (2020). Chromatin maturation of the HIV-1 provirus in primary resting CD4+ T cells. PLoS Pathogens. 16(1). e1008264–e1008264. 21 indexed citations

Mortera‐Blanco, Teresa, Marios Dimitriou, Thibault Bouderlique, et al.. (2019). A three-dimensional in vitro model of erythropoiesis recapitulates erythroid failure in myelodysplastic syndromes. Leukemia. 34(1). 271–282. 16 indexed citations

Dolinska, Monika B., Lakshmi Sandhow, Makoto Kondō, et al.. (2018). Sipa1 deficiency–induced bone marrow niche alterations lead to the initiation of myeloproliferative neoplasm. Blood Advances. 2(5). 534–548. 28 indexed citations

Mortera‐Blanco, Teresa, Marios Dimitriou, Petter Woll, et al.. (2017). SF3B1-initiating mutations in MDS-RSs target lymphomyeloid hematopoietic stem cells. Blood. 130(7). 881–890. 47 indexed citations

10.

Scharenberg, Christian, Valentina Giai, Andrea Pellagatti, et al.. (2016). Progression in patients with low- and intermediate-1-risk del(5q) myelodysplastic syndromes is predicted by a limited subset of mutations. Haematologica. 102(3). 498–508. 29 indexed citations

11.

Heshmati, Yaser, Sten Linnarsson, Marios Dimitriou, et al.. (2016). Identification of CHD4 As a Potential Therapeutic Target of Acute Myeloid Leukemia. Blood. 128(22). 1648–1648. 4 indexed citations

12.

Dimitriou, Marios, Petter Woll, Teresa Mortera‐Blanco, et al.. (2016). Perturbed hematopoietic stem and progenitor cell hierarchy in myelodysplastic syndromes patients with monosomy 7 as the sole cytogenetic abnormality. Oncotarget. 7(45). 72685–72698. 16 indexed citations

13.

Tobiasson, Magnus, Donal P. McLornan, Mohsen Karimi, et al.. (2016). Mutations in histone modulators are associated with prolonged survival during azacitidine therapy. Oncotarget. 7(16). 22103–22115. 29 indexed citations

14.

Tobiasson, Magnus, Donal P. McLornan, Mohsen Karimi, et al.. (2015). Mutations in Histone Modulators Are Associated with Prolonged Survival during Azacitidine Therapy. Blood. 126(23). 2839–2839. 1 indexed citations

15.

Conte, Simona, Shintaro Katayama, Liselotte Vesterlund, et al.. (2015). Aberrant splicing of genes involved in haemoglobin synthesis and impaired terminal erythroid maturation inSF3B1mutated refractory anaemia with ring sideroblasts. British Journal of Haematology. 171(4). 478–490. 30 indexed citations

16.

Yiakouvaki, Anthie, Marios Dimitriou, Ioannis Karakasiliοtis, et al.. (2011). Myeloid cell expression of the RNA-binding protein HuR protects mice from pathologic inflammation and colorectal carcinogenesis. Journal of Clinical Investigation. 122(1). 48–61. 107 indexed citations

17.

Dimitriou, Marios, et al.. (2007). Post-transcriptional Regulators in Inflammation: Exploring New Avenues in Biological Therapeutics. PubMed. 37–57. 12 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact